Days after Neuraxpharm announced that it had acquired the narcolepsy brands Provigil (modafinil) and Nuvigil (armodafinil) in the majority of non-US markets, the fate of the drugs’ US rights has been revealed.
Marking a “strategic milestone for Apotex and a significant initial step in growing our US specialty business,” the Canadian firm has announced that its affiliate Nuvo Pharmaceuticals has bought up...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Generics Bulletin for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?